Interact to see
Advertisement
Advertisement
CIRAX vs FEBAX
CIRAX vs FEBAX Comparison
Open Charts CIRAX vs FEBAX
American Funds Capital Income Bldr 529A
Price$76.62
Change+$0.31 (+0.41%)
VolumeN/A
Net Assets115.4B
First Eagle Global Income Builder A
Price$14.75
Change+$0.03 (+0.20%)
VolumeN/A
Net Assets1.97B
CIRAX vs FEBAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
CIRAX vs. FEBAX commentary
Jul 18, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIRAX is a Buy and FEBAX is a StrongBuy.
FUNDAMENTALS
Fundamentals
CIRAX has more cash in the bank: 115B vs. FEBAX (1.97B). CIRAX pays higher dividends than FEBAX: CIRAX (2.97) vs FEBAX (2.42). CIRAX was incepted earlier than FEBAX: CIRAX (23 years) vs FEBAX (13 years). FEBAX (1.17) is less costly to investors than CIRAX (0.62). CIRAX is a more actively managed with annual turnover of: 56.00 vs. FEBAX (14.66). FEBAX initial investment is less costly to investors than CIRAX (4%) vs CIRAX (4%). CIRAX has a lower initial minimum investment than FEBAX: CIRAX (250) vs FEBAX (2500). FEBAX annual gain was more profitable for investors over the last year : 13.15 vs. CIRAX (12.31). CIRAX return over 5 years is better than : 53.31 vs. FEBAX (43.62).
| CIRAX | FEBAX | CIRAX / FEBAX | |
| Total Expense Ratio | 0.62 | 1.17 | 53% |
| Annual Report Gross Expense Ratio | 0.62 | 1.17 | 53% |
| Fund Existence | 23 years | 13 years | - |
| Gain YTD | 12.532 | 14.354 | 87% |
| Front Load | 4% | 5% | 70% |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 115B | 1.97B | 5,832% |
| Annual Yield % from dividends | 2.97 | 2.42 | 123% |
| Returns for 1 year | 12.31 | 13.15 | 94% |
| Returns for 3 years | 36.62 | 34.55 | 106% |
| Returns for 5 years | 53.31 | 43.62 | 122% |
| Returns for 10 years | 79.22 | 67.22 | 118% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement